8th European Conference on Infections in Leukaemia: 2020 guidelines for the diagnosis, prevention, and treatment of invasive fungal diseases in paediatric patients with cancer or post-haematopoietic cell transplantation. Issue 6 (June 2021)

• Record Type: Journal Article
• Authors: Groll, Andreas H; Pana, Dorothea; Lanternier, Fanny; Mesini, Alessio; Ammann, Roland A; Averbuch, Dina; Castagnola, Elio; Cesaro, Simone; Engelhard, Dan; Garcia-Vidal, Carolina; Kanerva, Jukka; Ritz, Nicole; Roilides, Emmanuel; Styczynski, Jan; Warris, Adilia; Lehrnbecher, Thomas
• Is Part Of: Lancet oncology. Volume 22:Issue 6(2021)
• Page Start: e254
• Page End: e269
• Publication Date: 2021-06
• Subjects: Oncology -- Periodicals; Neoplasms -- Periodicals; Cancérologie -- Périodiques; Oncologie; Oncology; Periodicals; Electronic journals; 616.994005
• DOI: 10.1016/S1470-2045(20)30723-3
• Languages: English
• ISSNs: 1470-2045

Abstract

Summary: Paediatric patients with cancer and those undergoing allogeneic haematopoietic cell transplantation have an increased susceptibility to invasive fungal diseases. In addition to differences in underlying conditions and comorbidities relative to adults, invasive fungal diseases in infants, children, and adolescents are unique in terms of their epidemiology, the validity of current diagnostic methods, the pharmacology and dosing of antifungal agents, and the absence of phase 3 clinical trials to provide data to guide evidence-based interventions. To re-examine the state of knowledge and to further improve invasive fungal disease diagnosis, prevention, and management, the 8th European Conference on Infections in Leukaemia (ECIL-8) reconvened a Paediatric Group to review the literature and to formulate updated recommendations according to the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and European Confederation of Medical Mycology (ECMM) grading system, which are summarised in this Review.